| | |  | | | | Record from Web of Science® | | | | | | |
| Genomics and intellectual property rights |
|
|
| Author(s): Thomas SM |
| Source: DRUG DISCOVERY TODAY Volume: 4 Issue: 3 Pages: 134-138 Published: MAR 1999 |
| Times Cited: 6 References: 12 |
| Abstract: Issues that concern intellectual property (IP) rights in biotechnology have become increasingly focused on genomics. IP protection in genomics often involves patenting DNA and it is on this aspect that much of the complexity and controversy has centred. Genomics has also stimulated the development of new technologies crucial to the exploitation of the large volume of information that genomics is beginning to generate. IP rights for some of these technologies are being vigorously pursued. Because the structural and functional analysis of human and other genomes has central significance to many areas of the life sciences and to developments in healthcare, questions over accessibility and appropriability of genomic information are being widely debated. In this article the factors shaping IP rights in genomics are explored together with the probable implications. The patenting strategies of industry, including the multinational pharmaceutical firms and the small, specialized firms, are considered together with those of the public sector. |
| Document Type: Review |
| Language: English |
| Reprint Address: Thomas, SM (reprint author), Nuffield Council Bioeth, 28 Bedford Sq, London WC1B 3EG, England |
Addresses:
1. Nuffield Council Bioeth, London WC1B 3EG, England |
| Publisher: ELSEVIER SCI LTD, THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND |
| Subject Category: Pharmacology & Pharmacy |
| IDS Number: 180WK |
| ISSN: 1359-6446 |
|
| | | | | | | | | Record from Web of Science® | | | | | | | | | |